Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial Safety of Testosterone Patch in Postmenopausal Women with HSDD
NCT00467259Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Apr 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in hypoactive sexual desire disorder (HSDD), sponsored by Warner Chilcott. Started Apr 2007; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00467259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467259.